Balmer Lawrie & Co. Board Meeting Adjourned to May 17, 2026 for Q4 FY26 Results
Balmer Lawrie & Co. Ltd. adjourned its Board of Directors' meeting held on 15th May, 2026 to 17th May, 2026, following a request by Statutory Auditors for additional time to finalize their report. The adjourned meeting will consider audited standalone and consolidated financial results for Q4 and the financial year ended 31st March, 2026, a final dividend recommendation, and a capital restructuring review covering possible buyback, bonus shares, and share splitting. The Trading Window remains closed from 1st April, 2026 until 19th May, 2026.

*this image is generated using AI for illustrative purposes only.
Balmer Lawrie & Co . Ltd., a Government of India Enterprise, notified the stock exchanges on 15th May, 2026 that its Board of Directors' meeting, which commenced on the same date at 12:00 noon and continued till 4:00 p.m., was adjourned with the consent of the Chairman and all Directors present. The adjournment was necessitated after the Statutory Auditors requested additional time for the finalization of their Statutory Auditor's Report.
Adjourned Meeting Scheduled for May 17, 2026
The adjourned Board Meeting is set to resume on Sunday, 17th May, 2026. The company has communicated this development to both the National Stock Exchange of India Limited and BSE Limited in accordance with the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended).
The following key agenda items are scheduled for consideration at the adjourned meeting:
| Agenda Item: | Details |
|---|---|
| Financial Results: | Audited Standalone and Consolidated results for Q4 and Financial Year ended 31st March, 2026 (subject to prior review by the Audit Committee) |
| Dividend Recommendation: | Recommendation of final dividend, if any, on Equity Shares for the Financial Year ended 31st March, 2026 |
| Capital Restructuring Review: | Review of compliance with Consolidated Guidelines on general principles and mechanism for Capital Restructuring of CPSEs issued by Ministry of Finance, DIPAM — including possible deliberation on buyback of shares, issuance of Bonus Shares, and splitting of shares |
Trading Window Closure
In line with the company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relative of Designated Persons, framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended), the Trading Window status is as follows:
| Parameter: | Details |
|---|---|
| Closed Since: | Wednesday, 1st April, 2026 |
| Applicable To: | Designated Persons and their immediate relatives, and Insiders |
| Closure Until: | 48 hours after the declaration of financial results, i.e., till 19th May, 2026 |
The company has reiterated this closure in reference to its earlier intimations dated 25th March, 2026 and 5th May, 2026. The outcome of all agenda items considered at the adjourned Board Meeting on 17th May, 2026 will be communicated to the stock exchanges following the conclusion of the meeting, as required under applicable SEBI regulations. The intimation was signed by Kavita Bhavsar, Company Secretary and Compliance Officer, on behalf of Balmer Lawrie & Co. Ltd.
Historical Stock Returns for Balmer Lawrie & Co
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.25% | -1.13% | +15.71% | +1.39% | -11.46% | +42.10% |
What specific audit concerns prompted the Statutory Auditors to request additional time, and could these signal any material changes to Balmer Lawrie's FY2026 financial performance compared to previous years?
How might the Board's deliberation on capital restructuring options — buyback, bonus shares, or stock split — impact Balmer Lawrie's valuation and retail investor sentiment given its status as a Government of India Enterprise?
Will the delayed finalization of audited results affect Balmer Lawrie's dividend payout timeline or quantum, particularly in the context of DIPAM's guidelines on capital restructuring for CPSEs?


































